Showing 81 - 100 results of 269 for search '"chemotherapy"', query time: 0.05s Refine Results
  1. 81
  2. 82

    Cardiovascular Drug Therapy / by Messerli, Franz H.

    Published 1990
    Subjects:
    View in OPAC
    Book
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89

    The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma by Wu Y, Zhu J, Zhang H, Xia N

    Published 2025-02-01
    Subjects: “…drug-eluting beads-transarterial chemoembolization-hepatic arterial infusion chemotherapy…”
    Get full text
    Article
  10. 90

    The Harriet Lane handbook of pediatric antimicrobial therapy /

    Published 2009
    Subjects: “…Communicable diseases in children Chemotherapy Handbooks, manuals, etc. 763…”
    View in OPAC
    Book
  11. 91

    The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data by Peter J. Mallow, Jie Chen, John A. Rizzo, John R. Penrod, Geralyn C. Trudel, Teresa M. Zyczynski

    Published 2016-10-01
    “…The cohorts were: localized cancer not treated with chemotherapy, localized cancer treated with chemotherapy, and metastatic cancer. …”
    Get full text
    Article
  12. 92

    Perivascular space imaging during therapy for medulloblastoma. by Ruitian Song, John O Glass, Shengjie Wu, Yimei Li, Giles W Robinson, Amar Gajjar, Thomas E Merchant, Wilburn E Reddick

    Published 2025-01-01
    “…The impact of radiotherapy and chemotherapy on PVS remains unclear. The aim of this study is to investigate treatment effects of radiotherapy and chemotherapy at four time points (TPs) in pediatric medulloblastoma (MB) patients. …”
    Get full text
    Article
  13. 93

    Postpartum choriocarcinoma complicated by uterine perforation: A case report and literature review by Rayan R. Salahaldin, Mais E. Abubaker, Ghada M. Abdalqader, Anas R. Tuqan, Basel A. Zaben, Iba Barghouthi

    Published 2025-03-01
    “…Despite initial single-agent chemotherapy, disease progression led to uterine perforation and hemoperitoneum, requiring emergency surgery. …”
    Get full text
    Article
  14. 94

    A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma by Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally

    Published 2016-10-01
    “…Comparison with conventional chemotherapy was based on data from the Canadian British Columbia Cancer Agency registry from 40 patients starting salvage chemotherapy after front-line treatment between 1980 and 2012. …”
    Get full text
    Article
  15. 95

    The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma by Andrew C. Kidd, Gordon W. Cowell, Geoffrey A. Martin, Jenny Ferguson, Dean A. Fennell, Matt Evison, Kevin G. Blyth

    Published 2024-01-01
    “…Pre-chemotherapy sarcopenia and adipopenia were defined using validated thresholds, where available or indices <25th percentile. …”
    Get full text
    Article
  16. 96

    Current Status of Diagnosis and Treatment of High-risk Resistant and Recurrent Gestational Trophoblastic Neoplasia by MAO Mingyi, JIANG Fang, XIANG Yang

    Published 2024-04-01
    “…High-risk patients have a higher risk of resistance to single-agent chemotherapy and require combination chemotherapy. Even worse, there are some high-risk patients who develop resistance to combination chemotherapy or experience recurrence after cure. …”
    Get full text
    Article
  17. 97

    Prognostic factors in hereditary breast cancer: A review by Ziske Maritska, Sarmoko

    Published 2024-08-01
    “…Despite this, BRCA mutation carriers exhibit higher sensitivity to platinum-based chemotherapy and PARP inhibitors, potentially improving outcomes. …”
    Get full text
    Article
  18. 98

    Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer by O. Yu. Stukalova, A. A. Polikarpov, A. V. Moiseenko, D. A. Granov

    Published 2023-05-01
    “…Liver resection could not be performed due to the small future residual volume, and systemic chemotherapy was not effective. The patient underwent 3 cycles of regional chemotherapy. …”
    Get full text
    Article
  19. 99

    Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer by Xiaxia Chen, Wei Zhang, Lan Luo, Shimei Fu, Dongdong Cao, Shengfa Su, Qingsong Li, Wengang Yang, Yichao Geng, Bing Lu, Weiwei Ouyang

    Published 2024-09-01
    “…The number of median chemotherapy cycles was 4 (2–6), and the cut‐off value of the planning target volume (PTV) dose of the primary tumor was 63 Gy (30–76.5 Gy). …”
    Get full text
    Article
  20. 100

    NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis by Chaoqun Xing, Lipeng Zhao, Weiwei Zou, Xie Peng, Xiao-Liang Xing, Jie Li

    Published 2025-02-01
    “…Sensitivity analysis of chemotherapy drugs showed that NOS2 was significantly correlated with several chemotherapy drugs, such as MG.132_1862, BMS.754807_2171, and GEN.317_1926. …”
    Get full text
    Article